Literature DB >> 11574586

Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.

L E Lindler1, W Fan, N Jahan.   

Abstract

We have developed a fluorescence resonance energy transfer (FRET)-based assay to detect ciprofloxacin resistant (Cp(r)) mutants of the biothreat agent Yersinia pestis. We selected spontaneous mutants of the attenuated Y. pestis KIM 5 strain that were resistant to a ciprofloxacin (CIP) concentration of at least 1 microg/ml. DNA sequencing of gyrA encoded by 65 of these mutants revealed that all isolates contained one of four different point mutations within the quinolone resistance-determining region of gyrA. We developed a FRET-based assay that detected all of these mutations by using a single pair of fluorescent probes with sequences complementary to the wild-type Y. pestis gyrA sequence. Melting peak analysis revealed that the probe-PCR product hybrid was less stable when amplification occurred from any of the four mutant templates. This instability resulted in the PCR product obtained from the Cp(r) Y. pestis strains displaying a 4 to 11 degrees C shift in probe melting temperature. Following optimization of the reaction conditions, we were able to detect approximately 10 pg of purified wild-type template DNA or the presence of approximately 4 CFU of wild-type Y. pestis KIM 5 or Cp(r) mutants in crude lysates. Taken together, our results demonstrate the utility of FRET-based assays for detection of Cp(r) mutants of Y. pestis. This method is both sensitive and rapid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574586      PMCID: PMC88402          DOI: 10.1128/JCM.39.10.3649-3655.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Extraordinary infections: a focus on bioterrorism.

Authors:  J Grabenstein; K Downs; D Dotson
Journal:  J Am Pharm Assoc (Wash)       Date:  2000 Sep-Oct

Review 2.  The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective.

Authors:  C J Thomson
Journal:  J Antimicrob Chemother       Date:  1999-03       Impact factor: 5.790

3.  Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.

Authors:  H Mouneimné; J Robert; V Jarlier; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.

Authors:  Y W Chu; E T Houang; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

5.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

6.  A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York.

Authors:  A R Moss; D Alland; E Telzak; D Hewlett; V Sharp; P Chiliade; V LaBombardi; D Kabus; B Hanna; L Palumbo; K Brudney; A Weltman; K Stoeckle; K Chirgwin; M Simberkoff; S Moghazeh; W Eisner; M Lutfey; B Kreiswirth
Journal:  Int J Tuberc Lung Dis       Date:  1997-04       Impact factor: 2.373

7.  Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay.

Authors:  D L Wilson; S R Abner; T C Newman; L S Mansfield; J E Linz
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

8.  Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis.

Authors:  G Zirnstein; Y Li; B Swaminathan; F Angulo
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.

Authors:  T Takenouchi; E Sakagawa; M Sugawara
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

10.  gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.

Authors:  L M Weigel; C D Steward; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more
  15 in total

1.  Detection of rpoB mutations in Mycobacterium tuberculosis with LightCycler technology.

Authors:  Maria J Torres; Antonio Criado; Jose C Palomares; Javier Aznar
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Authors:  A Louie; H S Heine; B VanScoy; A Eichas; K Files; S Fikes; D L Brown; W Liu; M Kinzig-Schippers; F Sörgel; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 4.  Applications of polymerase chain reaction-based methods for the diagnosis of plague (Review).

Authors:  Yanan Zhang; Zhanli Wang; Wenrui Wang; Hui Yu; Min Jin
Journal:  Exp Ther Med       Date:  2022-06-14       Impact factor: 2.751

5.  Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus.

Authors:  Pascal Lapierre; Ann Huletsky; Véronique Fortin; François J Picard; Paul H Roy; Marc Ouellette; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography.

Authors:  William Hurtle; Luther Lindler; Wei Fan; David Shoemaker; Erik Henchal; David Norwood
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Ambient stable quantitative PCR reagents for the detection of Yersinia pestis.

Authors:  Shi Qu; Qinghai Shi; Lei Zhou; Zhaobiao Guo; Dongsheng Zhou; Junhui Zhai; Ruifu Yang
Journal:  PLoS Negl Trop Dis       Date:  2010-03-09

8.  Ciprofloxacin susceptibility of Pseudomonas aeruginosa isolates from keratitis.

Authors:  J A Lomholt; M Kilian
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

9.  Diagnostic bioluminescent phage for detection of Yersinia pestis.

Authors:  David A Schofield; Ian J Molineux; Caroline Westwater
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

10.  Genome-level transcription data of Yersinia pestis analyzed with a new metabolic constraint-based approach.

Authors:  Ali Navid; Eivind Almaas
Journal:  BMC Syst Biol       Date:  2012-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.